Diabetes, Obesity & Metabolism

Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes

By Giacomo Ruotolo, Charles Harris, Yanzhu Lin, Stephen James Nicholls

Randomised trial in peopleInterventions

Double-blind, placebo-controlled, registered NCT04881760

The paper

Giacomo Ruotolo, Charles Harris, Yanzhu Lin, Stephen James Nicholls

Eli Lilly (United States); Monash University

Diabetes, Obesity & Metabolism, 17 Aug 2026

doi.org/10.1111/dom.71200 PubMed 42608321

Medicine10 Oct 2026
Cholesterol-inflammation index linked to higher diabetes risk
The Journal of the Egyptian Public Health Association5 Oct 2026
Lipid accumulation index linked to cardiometabolic multimorbidity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Frontiers in Endocrinology4 Oct 2026
Six blood metabolites distinguish metabolic health in obesity